THERAVANCE BIOPHARMA, INC. (TBPH) Revenue 2016–2025
THERAVANCE BIOPHARMA, INC. (TBPH) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$107.5MFY2025 · since FY2016: $48.6M → $107.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $107.5M | +66.9% |
| FY2024 | $64.4M | +12.1% |
| FY2023 | $57.4M | +11.8% |
| FY2022 | $51.3M | -7.2% |
| FY2021 | $55.3M | -23.0% |
| FY2020 | $71.9M | -2.1% |
| FY2019 | $73.4M | +21.6% |
| FY2018 | $60.4M | +292.4% |
| FY2017 | $15.4M | -68.4% |
| FY2016 | $48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice